Zhitong Finance App News, China Pharmaceutical (600056.SH) issued an announcement. On July 31, 2026, the company's subsidiaries participated in the bid for the 12th batch of centralized national drug procurement. According to the proposed selection results announced on-site by the State Organization Drug Joint Procurement Office, the company's products betahistine hydrochloride tablets, vonoracin fumarate tablets, vitamin B6 injections, sacubatrivalsartan tablets, esaconazole sulfate tablets, edoxaban toluene sulfonate tablets, carosulfonate injections, and valaciclovir hydrochloride tablets are to be selected for this centralized procurement.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.